Treatment with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Does Not Affect Outcome in Patients with Acute Myocarditis or Myopericarditis.
Moritz MirnaLukas SchmutzlerAlbert TopfElke BoxhammerBrigitte SiposUta C HoppeMichael LichtenauerPublished in: Journal of cardiovascular development and disease (2022)
Background: Previous animal studies reported an association of non-steroidal anti-inflammatory drugs (NSAIDs) with adverse outcomes in acute myocarditis, which is why these drugs are currently not recommended in affected patients. In this retrospective case-control study, we sought to investigate the effects of NSAID treatment in patients with acute myocarditis and myopericarditis to complement the available evidence. Method: A total of 114 patients with acute myocarditis were retrospectively enrolled. Demographical, clinical and laboratory data were extracted from hospital records. Patients who received NSAIDs ( n = 39, 34.2%) were compared to controls. Follow-up on all-cause mortality was acquired for two years. Propensity score matching was additionally conducted to account for covariate imbalances between groups. Results: Treatment with NSAIDs was neither associated with a worse outcome ( p = 0.115) nor with significant differences in left ventricular systolic function ( p = 0.228) or in-hospital complications ( p = 0.507). Conclusion: Treatment with NSAIDs was not associated with adverse outcomes in our study cohort. Together with the findings of previous studies, our results indicate that these drugs could be safely administered in patients with myocarditis and myopericarditis.
Keyphrases
- anti inflammatory drugs
- left ventricular
- heart failure
- electronic health record
- acute myocardial infarction
- newly diagnosed
- atrial fibrillation
- combination therapy
- ejection fraction
- intensive care unit
- hypertrophic cardiomyopathy
- risk factors
- big data
- drug induced
- extracorporeal membrane oxygenation
- chronic kidney disease
- deep learning
- mechanical ventilation
- data analysis